The featured speakers... at 08:30 U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial Novavax, Inc. , a global company advancing ...
Health professionals recommend vaccines before traveling to celebrate the holidays with family. If you missed the early fall ...
B.Riley Financial analyst Mayank Mamtani has maintained their neutral stance on MGNX stock, giving a Hold rating today. Mayank Mamtani’s ...
Novavax said on Tuesday that it has entered into a termination and settlement agreement with the UK Health Security Agency ...
Plus, options traders eye NVAX; CMI surges to fresh peak; and CE looks to extend losing streak.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback